CA1123698A - Arrangement for intravenous administration or the like - Google Patents

Arrangement for intravenous administration or the like

Info

Publication number
CA1123698A
CA1123698A CA309,153A CA309153A CA1123698A CA 1123698 A CA1123698 A CA 1123698A CA 309153 A CA309153 A CA 309153A CA 1123698 A CA1123698 A CA 1123698A
Authority
CA
Canada
Prior art keywords
liquid
passageway
membrane
arrangement
filter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA309,153A
Other languages
French (fr)
Inventor
Adrian R. Reti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMD Millipore Corp
Original Assignee
Millipore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millipore Corp filed Critical Millipore Corp
Application granted granted Critical
Publication of CA1123698A publication Critical patent/CA1123698A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/36Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests with means for eliminating or preventing injection or infusion of air into body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M2005/1401Functional features
    • A61M2005/1403Flushing or purging

Abstract

ARRANGEMENT FOR INTRAVENOUS ADMINISTRATION
OR THE LIKE

ABSTRACT OF THE DISCLOSURE
The arrangement comprises a passageway for receiving liquid for intra-venous administration (IV) or the like. A hydrophilic microporous mem-brane having a first pore size is disposed in the passageway at a first point so that all liquid passes through the microporous membrane at said first point. A microporous filter is disposed below the membrane in the passage-way to filter all liquid passing through the passageway at the second point.
The membrane has a bubble point high enough to withstand the expected head of liquid below it (the gravity head of the IV set). Should liquid from the-source as it proceeds through the passageway from the microporous membrane to the filter be exhausted, then when air or gas reaches the mem-brane the flow of liquid is stopped because the upper, microporous mem-brane acts as an automatic shut-off valve. Air does not pass through the wet hydrophilic microporous membrane as long as the pressure does not exceed its bubble point. Accordingly there is no danger of air arriving at or passing through the microporous membrane to air-lock the lower passage way. A bellows drip chamber may be arranged in the passageway immediately below the membrane and may act as a drip chamber.
A further embodiment comprises such a bellows drip chamber arranged in the passageway below and immediately adjacent the microporous mem-brane, and a branch in the passageway in the section between the drip chamber and the hydrophilic filter is used for the application of a secondary or auxiliary solution. In such a case, if the source of the secondary solu-tion is higher than the source of the primary solution, the secondary solu-tion will be preferentially administered. There will be no back-flow because air or gas in the bellows or drip chamber will act as an air lock and prevent the backward flow of liquid in the first passageway because air or gas can-not pass through the hydrophilic upper microporous membrane which is wet by the liquid above it.

Description

~l Background of the Invention ;', . I .
It is known to use a hydrophilic filter to filter liquid as it flows in a ,~ paSsageway for intravenous adrninistratlon or the like. ~here is atways i~ some danger of gas or air in the liquid reaching the patient's veins and causing a serious hazard. One of the ways in which this problem has been attacked is to insert in a filter chamber holding the hydrophilic filter a hydrophobic membrane to vent air or gas that may cotlect in the filter cham~er, the gas-free liquid then passing through the hydrophilic filter.
~here is, nevertheless, a possibility that the hydrophobic membrane, being fragile, may rupture and cause contamination of the tiquid, or that the flow of liquid may be blocked by the collection of air or gas in the passageway.
i Various arrangements have been proposed for the application of a secondary or "piggyback" solution higher than the primary solution, to be ~j preferentially administered to the patient. Such arrangements usually in-,~ volve a branch from the passageway through which liquid is provided from the principal or main solution. ~he branch leads to a piggyback solution.
' It ha3 also been proposed to employ various valves or the li~ie to ass~re the preferential administration of the secondary solution until exhaustion whereupon the flow of the primary solution takes up or begins again. 'The following patents may be considered as exemplary: U. S~ paten~ 3,886, 937 of June 3, 1975 to Bobo, et al; U. S. patent 3, 982,534 of September 28, 1976 to Buckman; and U. S. patent 3,993, 066 of November 23, 1976 to Virag.
Note also the U. S, patent 3, 854, 907 of December 17, 1974 to Rising, A prior art patent which exemplifies the venting of air or gas through a hydrophobic 11 _z_ ~ ', - ~, , `"' ~ i ~. 236~3 filter from a liquid being filtered for a patient is the above-identified Rising patent. Note also U. S. patent 4,013,072 to Jess. Prior patents which exemplify mechanical valving for adminLstration of so-called ~'piggy-back" solutions are U. ~. patent 3, 886, 937 issued June 3, 1975 to Bobo, et al, and U. S. patent 3,982,534 issued September 28, 1976 to Buckman, the latter also having means for removing air bubbles from the flow of liquid, and U. S. patent 3,993,066 issued November 23, 1976 to Virag.
, . I, ,I Summary of the Invention ~
~ . I
i According to the invention, an arrangement for the intravenous 11 administration of liquid from a source comprises a liquid passageway, which ¦l may be exemplified by polyvinyl chloride tubing and which in operation has an orientation for the gravitational flow of liquid through the passageway A
hydrophilic microporous membrane is disposed at a point in the passageway so that all of the liquid passing through the passageway at that point passes ! through the membrane. By such a membrane, for this purpose, is meant .i any structure which has the requisite uniformity of pore size to afford a Il defined bubble point. Such a membrane may be similar to those used for ¦! microporous filters. It is important from a production standpoint that Il membranes made for the purpose have a ~;nown controllable and predictable ~ bubble point, so that if made in quantity none has a bubble point too large or too small. l~he bubble point of the membrane should exceed any pressure arising from the head of liquid at its expected location above the patient.
'rhe bubble point should also be sufficiently low to afford an ease of pumping action in priming the line as hereinafter described. A bubble point ¦
of between about 2 psi and 5 psi for the membrane is recommended.
A resilient walled chamber may be arranged in the passageway ¦ immediately below the membrane and may act also as a drip chamher. A
hydrophilic microporous filter is disposed in the passageway to filter all i _3 ~3.;~36~3 the liquid passing through the passageway at a lower point than the mem-brane.
In operation a liquid for intravenous administration is supplied from a suitable source, such as a container or bottle to the passageway from above the membrane. ~he passageway leading to the patient is first completely filled with liquid which may be conveniently and easily accomplished using the resilient wall to introduce and pump liquid in a fashion described in detail hereinafter. Administration of the liquid may ~, then begin. If the source fails, i. e. the container empties, all the liquid I will drain through the upper, coarse membrane. Nevertheless no air can intrude into the liquid column downstream of the microporous membrane because the bubble point of the upper, wet microporous structure is not exceeded. No air or gas can accumulate in the column between the two filters, in a fashion to be trapped and carried to the lower filter to air lock the filter. Consequently even if a container is replaced, the lower line remains emptied of air or gas, and replacement of the liquid container is - simplified without danger to the patient.
If it is desired to administer liquid from a piggyback solution, the passageway may include a branch and a chamber, say a drip chamber, between the branch and the microporous membrane, as here~ofore mentioned A second passageway connected to the branch may lead to a second source, the piggyback solution container, which, if the piggyback solution is to be i' preferentially administered, should be higher than the container for the ,I primary solution. Some air remains in the chamber under the microporous ii membrane, as is usual for a drip chamber. Under these conditions the il piggyback solution will be preferentially administered as long as the ievel -¦
,il of liquid from the piggyback container is higher than the level of the primary ' liquid. Backflow from the branch through the first passageway is prevented ,I because the air cannot flow from the drip chamber through the wet micro- ¦

,i. . .

.23~ 8 Ij porous membrane. Such backflow is prevented by the air lock, from the air ¦l allo~,ved to remain in the drip chamber, as the air cannot pass through the 'l wet microporous membrane as long as the back pressure does not exceed j'l the bubble point of this membrane. Consequently the preferential flow is , maintained. As soon as the level of liquid from the piggyback solution falls to a`point below the level of liquid from the primary container, or if flow from the piggyback solution is blocked, the flow from the primary container automatically is resumed .

.
Brief Description of the Drawings I
!~
I,l The various objects, advantages and novel features of the invention will ¦j be more fully apparent from the following detailed description when read in il connection with the accornpanying drawings in which:
:Fig. 1 i9 a front view, largely schematic of a first embodiment of the invention, ¦ Fig. 2 is a front view, largely schematic, of an embodiment of the ,1 invention for administration of a piggyback solution, and `' Fig. 3 is a partial view, illustrating a modification of the embodiment of Fig. 2.

Il Detailed Description l~eferring to Fig. 1, a support bar 10 supports an inverted container 12 j carrying a liquid 14 for intravenous infusion. The container 12 may be a ¦ bottle stoppered by a rubber stopper 16 through which is inserted a spike ¦
¦¦ 18 leading to a polyvinyl chloride tubing 20. The spike may have a mean3 ~not shown) of admitting air to replace liquid out-flow, as a Cutter's standard spike which has a check valve, or the container 12 may be collapsi- !
ble. The section of tubing 20 is held by a clamp 22 for selectively clamping off liquid flow and leads to the holder 24, The holder 24 may be a conven-tional filter holder carrying a microporous hydrophilic membrane 26. The outlet of the holder 24 leads in turn to a further section of polyvinyl !i . , ~ ' _ 5 chloride tubing 28. ~he tubing section 2~ carries a clamp 30 for selectively ~¦ clamping off flow. l~he tubing section 28 in turn leads to another filter ~¦ holder 32 in which is mounted a microporous hydrophilic filter 34, l~he Ij filter holder 32 is connected to a further tubing section 36 which leads to a cannula 38 suitable for insertion into a patient's vein.
i~ By way of example, upper membrane 26 may have a pore size of about ,' 5 microns to provide a bubble point of, say; between 2 and 5 psi, and the lower filter preferably has a pore size filtering against entry of microbial or bacterial invasion, for example a pore size of 0. 22 microns. It is recommended that the bubble point of the membrane 26, be greater than about two psi, and preferably less than about five psi. 'rhe upper, latter limit is desirable so that air may be forced readily and easily throu~h the rnembrane, by squeezing the flexible walls, as described more fully herein-', after. ~he lower limit is desirable so that there is a relatively low resis-tance to liquid flow, so that the liquid will flow through the membrane with sufficient freedom. Generally the exposed surface of the membrane may be less than that of the finer pore, downstream filter 34. ~he tubings 20, `,, 28 and 36 o Fig. I with the interposed filters constitute a passageway `~' which in operation is oriented for the gravitational flow of liquid through~I the passageway, first through the upper membrane 26 and then through the section 28 and through the lower filter 34. ~he holders 24 and 32 are such that at the points in which the respective membrane and filter are disposed any liquid flowing through the passageway rnust flow through them. ~he upper filter holder 24 rnay comprise immediately below the membrane 26 a bellows chamber (not illustrated) as clescribed in connection with Fig. 2.
Otherwise, preferably, holder 24 of Fig. I has resilient walls immediately below the filter membrane 26 thereby to act as a bellows, but need not have accordion-like walls, such illustraf ion (as in Fig. 2) being only a conven-tionalized showing in the drawing, ¦1 In operation the spike 18 is first entered into the stopper 16. ~he il liquid is allowed to flow through the passageway formed by the sections of jl tubings 20, 28 and 36 and the filter holders 24 and 32~ untSI liquid flows from the cannula 38. ~o accomplish the initial flo~,v of liquid, with clamp 3û
', applied, and clamp 22 relaxed, the resilient walls of holder 26 maybe squeezed, forcing air into the container 12. When the resilient walls are ~i relaxed, the differential pressure will force liquid against the filter mem- 1, i¦ brane and the flo~,v of liquid through this membrane and the passageway ¦I section 20 above the holder 24. Clamp 30 may now be relaxed and the jl pumping action may be repeated. When the resilient walls below the mem-brane is squeezedJ liquid is forced downward, because air left in the I¦ chamber is prevented by the wet membrane from passing through it. ~hus j liquid is forced down through the passageway. When the wall is relaxed, ' ¦ Iiquid flows through the membrane l:o fill the increased volume. ~his Ij repeated pumping action is continued until excess liquid flows from the ¦, cannula and all air is expelled from the passageway sections 28 and 36. A
¦ slight amount of air remains in holder 24, but above the tubing section 28 and in the chamber just below membrane 26. ~he tubing frorn the holder 32 to the tip of the cannula must be free of air~ ~he cannula may then be inserted in the patient's vein and administration begun.
~he upper membrane functions as an automatic shutoff valve whenthe;
supply bottle liquid 14 is emptied. 'rhe liquid below the upper membrane 26 can fall only far enough to reach equilibrium with the partial vacuum created i below the membrane 26. ~he bubble point of the mernbrane exceeds the hydraulic head at its Iocation. ~herefore the liquid downstream of the mem-¦ brane is prevented from completely flowing out. ~rhe downstream filter and line thus never receive air and cannot be air lo-ked. If a new bottie is to 1, .

~.Z36,~13 be inserted into the system, flow can be commenced irnmediately. It is Ii only necessary to withdraw the spike 18, hang a new bottle in place and in-.: .
sert the spike into the new bottle. Even if air has reached membrane 26 and flow has stopped, it is simple and convenient to replace the bottle. ~he spike may be withdrawn and inserted into a newly mounted bottle, and flow will begin again without danger of any air gaining access to the line below the holder 24. By using the membrane 26 having a relatively low bubble point (say between 2 and 5 psi) resumption of flow is facilitated and use of the clamp is not necessary. Further, it is easier to initiate flow through the filter having such a relatively Low bubble point when initially "priming"
the arrangement, than it ~ould be through a finer membrane.
Referring no~,v to Fig. 2, a holder 10 supports an inverted bottle or con-tainer 12 carrying the liquid 14 as in Fig. 1. Inthe arrangement of Fig. 2, however, the spiXe 18 leads directly to a holder 24' carrying microporous hydrophylic membrane 26'. Membrane 26' may have a pore size of five microns. Below and immediately adjacent the membrane holder 24' and preferably integral with this holder is a bellows drip chamber 27, which thence leads to a section of tubing 28, 28'. A branch 29 of tubing leads from the section 28, 28' by means of a Y, the upper section 28 being one li arm OI the Y the lower section 28 leading from the leg of the Y and the tubing 29 leading from the other arm of the Y. ~he tubing 29 carries a clamp 31 and leads to a spike 18' inserted in~o the stopper 16' of a secondary or so-called piggyback solution 14' carried in a container 12' on a support 10'. As frequently customary for piggyback containers, the container 12' is hung at a substantially higher level than the cont~iner 12, as indicated schematically by the break in the section 29 and by the arrows. As in the arrangement of Fig. 1, the microporous hydrophylic filter 34 of Fig. 2 may l -8-~ ~ z36~
have a pore size of 0. 22 microns.
In preparing the system for operation, assume that the clamps 31 and 37 are applied and spike 18' not yet inserted. The spike 18 is inserted into , the stopper 16 and the drip chamber bellows (which may be exemplified by a simple, resilient, transparent section of tubing) is pumped once manually.
Air is forced up through spil~e 18. As the bellows returns to its relaxed , position, it creates a vacuum in the drip chamber which tends to hasten il flow oî liquid and the wetting of the membrane 26 some liquid passing into iil the drip chamber. Then the clamp 31 is relaxed and the bellows compressed I repeatedly. ~s the membrane 26~ is wet, liquid is pumped during this step to fill tubing section 29 beyond clamp 31. Then clamp 31 is applied, clamp ,¦ 37 relaxed and the pumping repeated until all air is expelled frorn sections 28 and 36 to the cannula and all air absent from section 29. The cannula may then be inserted into the patient. The system is then locked against further air entry into the passageway section 28. Flow ~rom the carrying 1 .
solution bottle 12' through the branch passageway 29 thence through ¦¦ passageway section 28' toward the patient may be started or stopped at will Il by relaxing or impressing pressure from the clamp 31 on the section 29.

~i The carrying solution 14 may be readily renewed by removing the container ¦¦ 12 and replacing it with another, simply withdrawing the spike 16 and rein-¦¦ serting it in the fresh container. This is an important and useful feature, - ¦¦ saving time and simplifying renewal of the solution.

Before inserting the spike 18' air should be expelled from the remainder ii of the branch passageway or tubing 29. This may be done by relaxing il clamp 31 while clamp 37 is closed before the spike 18' is not inserted i. e.

is free. The spike 18' may then be held at a low level, below container 12, ¦ until liquid expells all the air from section 29 and from the spike 18'. Then ll l I, _ 9 _ ~

~23~

ij `.
i the spike 18' maybe inserted through the stopper 16'.
, When the clamps 31 ancl 37 are now relaxed, the piggyback solution, being at a higher level, will flow to the patient preferentially to the primary solution 14. The pressure differential created by the diEferent liquid levels is exerted against the trapped air or gas in the bellows chamber which cannot pass through the membrane 26~. An air lock is thus formed because the back pressure does not exceed the bubble point of the wet membrane. Thus back-flow is prevented. If the flow of the piggyback solution is to be stopped, Il that may be done by simply applying the pressure from the clamp 31 to closeil off the passageway or tubing 29 whereupon flow from the primary solution 14 through the primary passageway comprising holder 24', bellows drip '~, chamber 27, sections 23 and 28', holder 32 and section 36, resumes.
,1 If the piggyback solution 14' reaches to or below the level of the primary solution 1~, the latter will commence flowing, and the solutions will flow jointly. Normally at this point, a nurse removes the piggyback set, or re-places it.
However, it may be preferable to supply a filter holder and a membrane, at the spike 18' of the piggyback solution such as holder 24. Alternatively and preferably, as illustrated in the partial view of }~ig. 3 a holder 24" like , holder 24', with a membrane 26" like membrane 26' (and pasticularly having ~¦ a similar bubble point characteristic1, may be desirable for the piggyback solution. Such an arrangement also allows monitoring the flow of the piggy-back solution. Moreover, in such case the flow of the piggyback solution will cease, because of the bubble point o~ the wet membrane 26", when the piggyback solution is exhausted and reaches the membrane 26" thus supplied.
In initiating operat;on with a holder such as 24", similar considerations appLy as t~ose with respect to holder 24', namely all air should be carefully Il - 10- , 3~

expelled from the tubing between the holder 24'! and the filter 34, except for the small accumulation in the holder itseLf. Advantages similar to those for the similar arrangement with the primary solution are gained. A
single compression of the bellows 27' may be used to hasten wetting of membrane 26" and the flo~v of the piggyback solution. Replacement of the ., i solution is also simplified, as the spike 18" need only be inserted into the replacement container stopper even if the container 12" has previously been I j exhausted. -~1 In any of these arrangements it is clear that if operation is properly li initiated, air or gas cannot be entrained to be trapped in the tubing section Ij below the first filter holder. Such air or gas usually cannot rise in such ¦l tubing section to escape because the usual small diameter of the tubing pre-i~i vents such rise. A substantial advantage of the various embodlments dis-¦I closed herein is that replacement of containers of solution is facilitated and jl is readily accomplished by the nurse or attendant. No wiShdrawal and re- , ' ¦l insertion of the cannula is required, even if the container has emptied. In viel,v of the foregoing description it will be apparent that there is disclosed a novel and superior arrangement particularly suitable for the administration of i~ravenous solutions.

I
Il . ,

Claims (21)

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. An arrangement for the intravenous administration of liquid com-prising a liquid passageway, a hydrophilic membrane having a bubble point and disposed in said passageway, a hydrophilic filter disposed in said passageway, in operation said membrane being disposed above said filter, thereby to define an intermediate passageway section between them, whereby air passage through said membrane when wet is blocked and the replacement of a liquid supply for the administration is facilitated.
2. An arrangement as claimed in Claim 1, said bubble point exceeding the expected hydraulic head at its point of disposition in said passageway.
3. An arrangement as claimed in Claim 2, said membrane having a pore size to have a bubble point between 2 and 5 psi, thereby to ease of initiation of operation.
4. An arrangement for the intravenous administration of liquid, com-prising:
a liquid passageway having in operation an orientation for the gravita-tional flow of liquid therein, a microporous membrane having a bubble point and disposed in said passageway to receive and through which passes all liquid passing through said passageway at the point of disposition of said membrane, a microporous filter disposed in said passageway in such orientation at a lower point than said membrane to filter all liquid passing through said passageway at said lower point, whereby air passage through said membrane when wet is blocked and the replacement of a supply for said liquid is facilitated.
5. An arrangement as claimed in claim 4, said bubble point exceeding the expected hydraulic head at said membrane.
6. An arrangement as claimed in claim 4 further comprising a branch in said passageway between said membrane and said filter, and a second liquid passageway communicating with said first passageway at said branch.
7. An arrangement as claimed in claim 4, further comprising a drip chamber disposed in said passageway below said membrane in said orienta-tion, to receive all liquid flowing through said membrane, said membrane with gas in said chamber acting as an air lock against reverse flow of liquid from said branch.
8. An arrangement as claimed in claim 7, said drip chamber having resilient walls, to facilitate initiation of operation.
9. An arrangement as claimed in claim S, further comprising a drip chamber disposed in said passageway below and immediately adjacent said membrane, to receive all liquid flowing through said membrane, said chamber and said membrane affording an air lock against reverse liquid flow.
10. An arrangement for the intravenous administration of liquid from a source of liquid comprising:
a liquid passageway having in operation an orientation for the gravita-tional flow of liquid therein and having means for connection to said source, a first hydrophilic microporous membrane having a bubble point and disposed at a first point in said passageway below said means in such orienta-tion, said bubble point exceeding the expected hydraulic head at said mem-brane's point of disposition, said membrane being so arranged at said first point that the membrane receives and through it, passes all liquid passing said first point.
a microporous hydrophilic filter disposed in said passageway in such orientation at a lower, second point than said membrane to filter all liquid passing through said passageway at said lower point, thereby to facilitate replacement of said source.
11. An arrangement as claimed in claim 10, said passageway including a drip chamber between said branch and said membrane, air in said chamber in operation acting against said membrane to provide an air lock against reverse liquid flow.
12. An arrangement as claimed in claim 11, said drip chamber having transparent, resilient walls.
13. An arrangement as claimed in claim 12, said passageway comprising polyvinyl chloride tubing.
14. An arrangement as claimed in claim 12, said drip chamber being immediately adjacent said membrane.
15. An arrangement as claimed in claim 11, said passageway having a branch between said drip chamber and said filter.
16. An arrangement as claimed in claim 15, further comprising a second passageway having one end connected at said branch to said first passageway and having another end adapted for connection to a second source of liquid.
17. An arrangement as claimed in claim 16, said passageways com-prising polyvinyl chloride tubing.
18. An arrangement for the intravenous administration of liquid to facilitate replacement of a source of said liquid comprising:
a passageway comprising a first section having means for connection to a source of liquid a first filter holder connected to said section to receive liquid therefrom, a hydrophilic microporous membrane held by said first holder to receive and through which passes all liquid passing through said first holder, said membrane having a bubble point exceeding the expected hydraulic head against it, said passageway comprising a second section connected to receive liquid from said first holder, a second filter holder connected to said second section to receive liquid therefrom, and a hydrophilic microporous filter held by said second filter holder to filter all liquid passing through said second holder, said passageway comprising a third section to receive filtered liquid from said second filter.
19. An arrangement as claimed in claim 18, said first filter holder comprising a drip chamber immediately adjacent said membrane to receive liquid therefrom, and thus providing with said membrane during operation an air lock against reverse liquid flow.
20. An arrangement as claimed in claim 19, said bubble point being between 2 and 5 psi, to assure ease of initiation of operation.
21. An arrangement as claimed in claim 19, further comprising a branch passageway connected to said second passageway section.
CA309,153A 1977-08-15 1978-08-11 Arrangement for intravenous administration or the like Expired CA1123698A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US824,908 1977-08-15
US05/824,908 US4200095A (en) 1977-08-15 1977-08-15 Arrangement for intravenous administration or the like

Publications (1)

Publication Number Publication Date
CA1123698A true CA1123698A (en) 1982-05-18

Family

ID=25242614

Family Applications (1)

Application Number Title Priority Date Filing Date
CA309,153A Expired CA1123698A (en) 1977-08-15 1978-08-11 Arrangement for intravenous administration or the like

Country Status (7)

Country Link
US (1) US4200095A (en)
JP (1) JPS5452891A (en)
CA (1) CA1123698A (en)
DE (1) DE2835230C2 (en)
FR (1) FR2400367B1 (en)
GB (1) GB2002646B (en)
SE (1) SE7808607L (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4325368A (en) * 1978-12-16 1982-04-20 Ingrid Bernard Infusion device
US4361147A (en) * 1979-01-22 1982-11-30 Master Medical Corporation Flow control device for administration of intravenous fluids
WO1980001756A1 (en) * 1979-02-28 1980-09-04 Abbott Lab Equipment sets and systems for the sequential administration of medical liquids at dual flow rates
US4316460A (en) * 1979-02-28 1982-02-23 Abbott Laboratories Gravitational flow system for the sequential administration of medical liquids
US4278084A (en) * 1979-10-19 1981-07-14 Baxter Travenol Laboratories, Inc. Non air-blocking filter
US4335717A (en) * 1980-10-10 1982-06-22 Abbott Laboratories I.V. Administration set with retrograde volume
US4985017A (en) * 1981-07-13 1991-01-15 Alza Corporation Parenteral therapeutical system comprising drug cell
US4552555A (en) * 1981-07-31 1985-11-12 Alza Corporation System for intravenous delivery of a beneficial agent
US4857052A (en) * 1981-07-13 1989-08-15 Alza Corporation Intravenous system for delivering a beneficial agent
US5069671A (en) * 1981-07-13 1991-12-03 Alza Corporation Intravenous medication
US4973307A (en) * 1981-07-13 1990-11-27 Alza Corporation Method for administering drugs to a patient
US4790820A (en) * 1981-07-13 1988-12-13 Alza Corporation Parenteral agent dispensing equipment with drug releasing member
US4994031A (en) * 1981-07-13 1991-02-19 Alza Corporation Intravenous system for delivering a beneficial agent
USRE34365E (en) * 1981-07-13 1993-08-31 Intravenous system for delivering a beneficial agent
US4871360A (en) * 1981-07-31 1989-10-03 Alza Corporation System for intravenous delivery of a beneficial drug at a regulated rates
US4459139A (en) * 1981-09-14 1984-07-10 Gelman Sciences Inc. Disposable filter device and liquid aspirating system incorporating same
US4451255A (en) * 1982-05-20 1984-05-29 Abbott Laboratories Dual flow rate intravenous administration set with single pump chamber
US4908019A (en) * 1982-05-24 1990-03-13 Alza Corporation Apparatus comprising dual reservoirs for parenteral infusion of fluid containing beneficial agent
FR2549430B1 (en) * 1983-07-21 1986-03-21 Grenoble Inst Nal Polytechni DEVICE FOR FIXING A CABLE CAR OR A CABLE LIFT ON A CABLE PROVIDED WITH A ROLLING SURFACE FOR PULLETS
JPS6167744U (en) * 1984-10-08 1986-05-09
US4857555A (en) * 1985-09-12 1989-08-15 Brigham & Women's Hospital Method of treating catabolic dysfunction
US5039704A (en) * 1985-09-12 1991-08-13 Brigham And Women's Hospital Method of treating catabolic dysfunction
US5607975A (en) * 1985-09-12 1997-03-04 Brigham And Women's Hospital Method of treating catabolic, gut-associated pathological processes and impaired host defenses
US5397803A (en) * 1985-09-12 1995-03-14 Brigham And Women's Hospital Use of glutamine to reduce rate of pathogenic microorganism infection
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
US5763485A (en) * 1985-09-12 1998-06-09 Brigham And Women's Hospital Method of treating catabolic, gut-associated pathological processes and impaired host defenses
US5070899A (en) * 1986-11-03 1991-12-10 Pall Corporation Check valve
AU587949B2 (en) * 1987-08-26 1989-08-31 Cobe Laboratories Inc. Sterile blood component collection
US5032112A (en) * 1989-11-22 1991-07-16 Baxter International Inc. Dual source intravenous administration set having an intravenous pump
DE4000457C1 (en) * 1990-01-09 1991-04-18 Pfrimmer-Viggo Gmbh & Co Kg, 8520 Erlangen, De Drip feed supply appts. - comprises hollow needle piercing vertically held container so that tip emerges from top for attachment to holder
US5292722A (en) * 1992-11-06 1994-03-08 Brigham And Women's Hospital Intravenous solution that diminishes body protein loss
CA2188953A1 (en) * 1994-04-28 1995-11-09 Harry Leibitzki One-piece dispensing device for the contamination-free administration of medicaments (cytostatica)
US5902281A (en) * 1995-03-22 1999-05-11 Teva Medical Ltd. Drip chamber for intravenous infusion
US6071269A (en) 1998-05-13 2000-06-06 Medisystems Technology Corporation Blood set and chamber
US6641556B1 (en) * 1999-07-06 2003-11-04 Respiratory Support Products, Inc. Intravenous fluid heating system
MXPA05000816A (en) 2002-07-19 2005-04-28 Baxter Int Systems and methods for performing peritoneal dialysis.
FR2862880B1 (en) * 2003-11-28 2006-10-20 Maco Pharma Sa INFUSION DEVICE COMPRISING A POCKET PROVIDED WITH REVERSIBLE SEALING MEANS
US7722577B2 (en) * 2005-02-18 2010-05-25 Becton, Dickinson And Company Bubble free—self primed IV set
US8282608B2 (en) * 2004-01-29 2012-10-09 Becton, Dickinson And Company Self priming intravenous delivery system
US8523829B2 (en) * 2004-01-29 2013-09-03 Becton, Dickinson And Company Intravenous delivery system
US7892332B2 (en) * 2007-10-01 2011-02-22 Baxter International Inc. Dialysis systems having air traps with internal structures to enhance air removal
US8444587B2 (en) 2007-10-01 2013-05-21 Baxter International Inc. Fluid and air handling in blood and dialysis circuits
US7892331B2 (en) * 2007-10-01 2011-02-22 Baxter International Inc. Dialysis systems having air separation chambers with internal structures to enhance air removal
US7871462B2 (en) * 2007-10-01 2011-01-18 Baxter International Inc. Dialysis systems having air separation chambers with internal structures to enhance air removal
US8123947B2 (en) * 2007-10-22 2012-02-28 Baxter International Inc. Priming and air removal systems and methods for dialysis
US8114276B2 (en) 2007-10-24 2012-02-14 Baxter International Inc. Personal hemodialysis system
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US20110276010A1 (en) * 2010-05-06 2011-11-10 Becton, Dickinson And Company Systems and methods for providing a closed venting hazardous drug iv set
US8382711B2 (en) 2010-12-29 2013-02-26 Baxter International Inc. Intravenous pumping air management systems and methods
US8974414B2 (en) 2013-02-13 2015-03-10 Becton, Dickinson And Company IV drip chamber with filter and bottom reservoir
CN103611203B (en) * 2013-11-20 2017-08-25 广东工业大学 Disposable auto-stopping streaming liquidproof Residual-type transfusion device
CN104096285A (en) * 2014-07-02 2014-10-15 广东工业大学 Disposable float type automatic liquid stop duplex-discharge infusion apparatus
US9486590B2 (en) 2014-09-29 2016-11-08 Fenwal, Inc. Automatic purging of air from a fluid processing system
US9833564B2 (en) * 2014-11-25 2017-12-05 Medtronic Minimed, Inc. Fluid conduit assembly with air venting features
US20160213862A1 (en) * 2015-01-27 2016-07-28 Becton, Dickinson And Company Iv set having an air stop membrane
US20160213861A1 (en) * 2015-01-27 2016-07-28 Becton, Dickinson And Company Air stop membrane for maintaining a fluid column in an iv set
US10232130B2 (en) * 2015-03-26 2019-03-19 Becton, Dickinson And Company Anti-run dry membrane
US10201667B2 (en) 2015-03-26 2019-02-12 Becton, Dickinson And Company IV membrane attachment systems and methods
US10105899B2 (en) 2015-03-26 2018-10-23 Becton, Dickinson And Company IV membrane attachment systems and methods
US10702689B2 (en) 2015-03-26 2020-07-07 Becton, Dickinson And Company Auto-stop vent plug
US10646648B2 (en) 2015-04-01 2020-05-12 Becton, Dickinson And Company IV flow management systems and methods
CN116206744A (en) 2015-06-25 2023-06-02 甘布罗伦迪亚股份公司 Medical device systems and methods with distributed databases
US10625009B2 (en) 2016-02-17 2020-04-21 Baxter International Inc. Airtrap, system and method for removing microbubbles from a fluid stream
EP3559951B1 (en) 2016-12-21 2022-01-12 Gambro Lundia AB Medical device system including information technology infrastructure having secure cluster domain supporting external domain
CN111407963A (en) * 2020-05-10 2020-07-14 蔡永霞 Automatic medicine changing device for disposable multi-bottle infusion apparatus

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1182016A (en) * 1967-02-08 1970-02-25 Baxter Laboratories Inc Parenteral Administration of Liquids
US3650093A (en) * 1970-01-08 1972-03-21 Pall Corp Sterile disposable medicament administration system
FR2106918A5 (en) * 1970-09-29 1972-05-05 Rhone Poulenc Sa
US3677242A (en) * 1971-01-11 1972-07-18 Baxter Laboratories Inc Air block prevention system
US3886937A (en) * 1971-02-12 1975-06-03 American Hospital Supply Corp Medical administration set for dispensing plural medical liquids
US3978857A (en) * 1972-08-14 1976-09-07 American Hospital Supply Corporation System with filter for administrating parenteral liquids
US3970084A (en) * 1972-10-20 1976-07-20 Burron Medical Products, Inc. Intravenous injection apparatus and needle adapter with filter and method of making same
DE2340123A1 (en) * 1973-08-08 1975-02-20 Schwarzer Gmbh Fritz OVERCURRENT PROTECTION CIRCUIT
US3896733A (en) * 1973-10-18 1975-07-29 Pall Corp Autotransfusion apparatus
US3854907A (en) * 1973-12-10 1974-12-17 Millipore Corp Vented filter holder
US3993066A (en) * 1974-11-01 1976-11-23 Baxter Laboratories, Inc. Burette chamber for use with intravenous solution administration set
US3982534A (en) * 1975-01-10 1976-09-28 Buckman Thomas P Intravenous administration system
US4004587A (en) * 1975-06-13 1977-01-25 Baxter Travenol Laboratories, Inc. Parenteral liquid administration set with non-air blocking filter
US4013072A (en) * 1975-11-03 1977-03-22 Baxter Travenol Laboratories, Inc. Drip chamber for intravenous administration
NL179705C (en) * 1976-03-31 1986-11-03 Leer Koninklijke Emballage DEVICE IN PARTICULAR FOR THE INTRAVENOUS DELIVERY OF LIQUIDS.
US4116646A (en) * 1977-05-20 1978-09-26 Millipore Corporation Filter unit

Also Published As

Publication number Publication date
US4200095A (en) 1980-04-29
FR2400367B1 (en) 1985-07-05
SE7808607L (en) 1979-02-16
GB2002646B (en) 1982-01-20
FR2400367A1 (en) 1979-03-16
JPS5452891A (en) 1979-04-25
GB2002646A (en) 1979-02-28
DE2835230C2 (en) 1986-07-31
DE2835230A1 (en) 1979-03-01

Similar Documents

Publication Publication Date Title
CA1123698A (en) Arrangement for intravenous administration or the like
US4013072A (en) Drip chamber for intravenous administration
US7892204B2 (en) Membrane support for drip chamber
US4941875A (en) I.V. system for successive administration of two or more solutions at different rates
CA1068569A (en) Intravenous solution set having a constricted inner diameter portion
US5158533A (en) Combined cardiotomy/venous/pleural drainage autotransfusion unit with filter and integral manometer and water seal
US5423738A (en) Blood pumping and processing system
JP3463297B2 (en) Ventilation system
US4900308A (en) Gas elimination device
CA1070585A (en) Twin check valve pump system having fail-safe characteristic
US4116646A (en) Filter unit
EP0153928B1 (en) In-line filter
JPH10505518A (en) Drip chamber head
JPS583705B2 (en) Double filtration plasma exchange device
US6051136A (en) Disposable sterile apparatus for blood filtration with a system for optimizing the recovery of blood between pouches
JPH03207372A (en) Blood force feed and disposal system
EP1181065B1 (en) Infusion apparatus
EP0642801B1 (en) Disposable sterile apparatus for blood filtration with system for optimizing the recovery of blood between pouches
JPH0117704B2 (en)
GB1568414A (en) Automatic intravenous flow regulator
WO1988009188A1 (en) Infusion apparatus
CN210904413U (en) Transfusion tube
CN212282403U (en) Infusion apparatus capable of preventing falling off
JPH0773605B2 (en) Priming method of plasma exchanger
WO1989003697A1 (en) Collapsible solution container

Legal Events

Date Code Title Description
MKEX Expiry